🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
Vaccines are one of our most effective public health tools but many who nee...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-04
Trial ID
NCT02057263
Treatments Being Tested
The purpose of this placebo controlled study is to evaluate the safety and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-25
Trial ID
NCT01949090
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
This Phase 3 clinical trial is a double blind, placebo-controlled, randomiz...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT01940315
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of an in...
Status
Completed
Location
Heartland Research Associates, LLC
Start Date
2017-11-29
Trial ID
NCT03303625
Treatments Being Tested
This study will evaluate the safety and immunogenicity of a tetravalent den...
Status
Completed
Location
Center for Immunization Research, Johns Hopkins School of Public Health
Start Date
2016-02-01
Trial ID
NCT02879266
Treatments Being Tested
Invasive meningococcal disease and meningococcal meningitis caused by Neiss...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-12
Trial ID
NCT03714737
Treatments Being Tested
Immunoprophylaxis with two hepatitis B vaccinations following the hepatitis...
Status
Unknown
Location
Beijing Youan Hospital, Capital Medical University
Start Date
2018-06-10
Trial ID
NCT03476083
Treatments Being Tested